Research & Education
CURE Expert Connections
Email Sign Up
To start your customized experience click the start button
Customize your homepage by selecting specific cancer types.
Cancer of Unknown Primary
Diet and Exercise
Gastrointestinal stromal tumor
General Financial Topics
General Psychosocial Aspect Topics
Head & Neck Cancer
Mantle Cell Lymphoma
Metastatic Breast Cancer
Side Effect Management
Small Lymphocytic Lymphoma (SLL)
Advocacy & Research
Share Your Story
Newsletter Sign Up
Ovarian Cancer Heroes
Bone Health Champions
Terms & Conditions
Cure Media Group, LLC.
2 Clarke Drive
Cranbury, NJ 08512
Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.
Highlights from the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, where oncology professionals, patients and advocates from around the world gather to share the latest advances in the field.
With Addition of Checkpoint Inhibitors, Chemotherapy 'Not Going Away Anytime Soon'
With new ways to treat chemotherapy-induced side effects, it seems that chemotherapy, combined with checkpoint inhibitors, is here to stay for the foreseeable future, according to one expert.
Combinations May Be the Future of Liver Cancer Treatment
With a wealth of drugs available for the treatment of liver cancer, one expert explained how combination therapy may be where the future is headed.
A Trial for Every Patient and a Patient for Every Trial
R. Donald Harvey
One expert weighs the benefits and drawbacks of expanding clinical trials to be more inclusive and reflective of the general patient population with cancer.
What Patients Should Know About Genetic Testing and Hereditary Cancer Risk
A breast cancer survivor and hereditary cancer expert discussed how patients can find accurate information about genetic mutations.
Practice-Changing Treatments for Bladder Cancer
A medical oncologist discusses the findings of three clinical trials presented during the 2019 American Society of Clinical Oncology Annual Meeting.
Future of Renal Cell Carcinoma: Hope Is on the Horizon
One expert discusses the “extremely interesting and extremely dynamic” field of renal cell carcinoma, and how recent research and FDA actions could offer hope for patients and their doctors.
Limited Cancer-Related Fatigue Regression Highlights Need for Intervention
Kristie L. Kahl
While half of women with gynecologic cancer reported experiencing significant fatigue during treatment, only 8% of survivors had symptoms regress without intervention.
Pediatric Neuroblastoma Survivors Face Task Efficiency, Emotional Regulation Impairments
Kristie L. Kahl
Long-term survivors of pediatric neuroblastoma may be at an increased risk for neurocognitive impairment – in particular, due to age at diagnosis and the type of treatment received.
App Helps Move Glioblastoma From 'Terminal to Treatable, Powered by Patients'
Kristie L. Kahl
A glioblastoma (GBM)-specific app, called OurBrainBank, efficiently collected patients’ symptoms – offering many hope for future research, according to founder Jessica Morris.
Lung Cancer Stigmas Affect Patients Psychosocially, Lead to Worse Health Outcomes
Studies show that the social stigma can actually affect a patient’s level of care and lead to worse health outcomes.
Not a member?
Sign up now!
Continue without login
OPTIONAL INFORMATION: The following information helps us tailor CURE to fit your needs
Please type below what best describes your interests and click on the selection(s):
I am a:
Please list other: